• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

4,4'-联苯磺酰胺作为选择性非锌结合基质金属蛋白酶抑制剂的动力学特征

Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.

作者信息

Santamaria Salvatore, Nuti Elisa, Cercignani Giovanni, La Regina Giuseppe, Silvestri Romano, Supuran Claudiu T, Rossello Armando

机构信息

a Dipartimento di Farmacia , Università di Pisa , Pisa , Italy .

b Dipartimento di Biologia, Unità di Biochimica , Università di Pisa , Pisa , Italy .

出版信息

J Enzyme Inhib Med Chem. 2015 Dec;30(6):947-54. doi: 10.3109/14756366.2014.1000889. Epub 2015 Feb 19.

DOI:10.3109/14756366.2014.1000889
PMID:25694065
Abstract

We describe the characterisation of a series of 4,4'-biphenylsulfonamides as selective inhibitors of matrix metalloproteases MMP-2 and -13, two enzymes involved in cell invasion and angiogenesis. Double-inhibitor studies in the presence of acetohydroxamic acid show that these molecules do not bind the catalytic zinc. Moreover, two of the characterised inhibitors (11 and 19) act as non-competitive inhibitors, whereas the para-methyl ester derivative 13 behaves as a competitive inhibitor. This finding suggests that this class of molecules binds to a catalytic subsite, possibly the S1'-pocket. Moreover, since these compounds also act as inhibitors of carbonic anhydrases (CAs), another family of enzymes involved in cell invasion, they could be potentially useful as CA/MMP dual target inhibitors with increased efficacy as anticancer agents.

摘要

我们描述了一系列4,4'-联苯磺酰胺作为基质金属蛋白酶MMP-2和-13的选择性抑制剂的特性,这两种酶参与细胞侵袭和血管生成。在乙酰氧肟酸存在下的双抑制剂研究表明,这些分子不与催化锌结合。此外,所表征的两种抑制剂(11和19)表现为非竞争性抑制剂,而对甲基酯衍生物13表现为竞争性抑制剂。这一发现表明这类分子与一个催化亚位点结合,可能是S1'-口袋。此外,由于这些化合物还可作为碳酸酐酶(CAs)的抑制剂,碳酸酐酶是另一类参与细胞侵袭的酶,它们有可能作为CA/MMP双靶点抑制剂,作为抗癌剂具有更高的疗效。

相似文献

1
Kinetic characterization of 4,4'-biphenylsulfonamides as selective non-zinc binding MMP inhibitors.4,4'-联苯磺酰胺作为选择性非锌结合基质金属蛋白酶抑制剂的动力学特征
J Enzyme Inhib Med Chem. 2015 Dec;30(6):947-54. doi: 10.3109/14756366.2014.1000889. Epub 2015 Feb 19.
2
Biphenylsulfonamides as effective MMP-2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis.联苯磺酰胺类 MMP-2 有效抑制剂具有良好的抗白血病疗效:合成、体外生物学评价、分子对接和 MD 模拟分析。
Drug Dev Res. 2024 Sep;85(6):e22255. doi: 10.1002/ddr.22255.
3
Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors.发现1,1'-联苯-4-磺酰胺类作为一类新型强效且选择性的碳酸酐酶XIV抑制剂。
J Med Chem. 2015 Nov 12;58(21):8564-72. doi: 10.1021/acs.jmedchem.5b01144. Epub 2015 Nov 4.
4
Recent Research Advances in Selective Matrix Metalloproteinase-13 Inhibitors as Anti-Osteoarthritis Agents.选择性基质金属蛋白酶-13抑制剂作为抗骨关节炎药物的最新研究进展
ChemMedChem. 2017 Aug 8;12(15):1157-1168. doi: 10.1002/cmdc.201700349. Epub 2017 Jul 19.
5
New in Vivo Compatible Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitors.新型体内相容基质金属蛋白酶(MMP)-2 和 MMP-9 抑制剂。
Bioconjug Chem. 2018 Nov 21;29(11):3715-3725. doi: 10.1021/acs.bioconjchem.8b00618. Epub 2018 Oct 24.
6
Virtual screening identification and chemical optimization of substituted 2-arylbenzimidazoles as new non-zinc-binding MMP-2 inhibitors.虚拟筛选鉴定及取代 2-芳基苯并咪唑类化合物的化学优化作为新型非锌结合 MMP-2 抑制剂。
Bioorg Med Chem. 2020 Feb 1;28(3):115257. doi: 10.1016/j.bmc.2019.115257. Epub 2019 Dec 9.
7
Sulfonamide derivatives containing dihydropyrazole moieties selectively and potently inhibit MMP-2/MMP-9: Design, synthesis, inhibitory activity and 3D-QSAR analysis.含二氢吡唑部分的磺胺衍生物选择性且强效地抑制基质金属蛋白酶-2/基质金属蛋白酶-9:设计、合成、抑制活性及三维定量构效关系分析
Bioorg Med Chem Lett. 2015 Oct 15;25(20):4664-71. doi: 10.1016/j.bmcl.2015.08.026. Epub 2015 Aug 14.
8
Robust design of some selective matrix metalloproteinase-2 inhibitors over matrix metalloproteinase-9 through in silico/fragment-based lead identification and de novo lead modification: Syntheses and biological assays.通过计算机辅助/基于片段的先导化合物发现及从头先导化合物修饰实现一些选择性基质金属蛋白酶-2抑制剂相对于基质金属蛋白酶-9的稳健设计:合成与生物学测定
Bioorg Med Chem. 2016 Sep 15;24(18):4291-4309. doi: 10.1016/j.bmc.2016.07.023. Epub 2016 Jul 14.
9
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity.基于N-O-异丙基磺酰胺基的异羟肟酸酯作为基质金属蛋白酶抑制剂:活性筛选及体内抗血管生成活性
J Med Chem. 2015 Sep 24;58(18):7224-40. doi: 10.1021/acs.jmedchem.5b00367. Epub 2015 Aug 28.
10
Hydantoin based inhibitors of MMP13--discovery of AZD6605.基于海因衍生物的 MMP13 抑制剂——AZD6605 的发现。
Bioorg Med Chem Lett. 2013 Aug 15;23(16):4705-12. doi: 10.1016/j.bmcl.2013.05.089. Epub 2013 Jun 10.

引用本文的文献

1
Alpinumisoflavone against cancer pro-angiogenic targets: In silico, In vitro, and In ovo evaluation.朝藿定黄酮抑制癌症血管生成靶点的作用:体内外和鸡胚实验评价。
Daru. 2022 Dec;30(2):273-288. doi: 10.1007/s40199-022-00445-9. Epub 2022 Aug 4.
2
Exosite inhibition of ADAMTS-5 by a glycoconjugated arylsulfonamide.糖基化芳基磺酰胺抑制 ADAMTS-5 的外切酶活性。
Sci Rep. 2021 Jan 13;11(1):949. doi: 10.1038/s41598-020-80294-1.
3
Inhibition of matrix metalloproteinases: a troubleshooting for dentin adhesion.基质金属蛋白酶的抑制:牙本质黏附的故障排除
Restor Dent Endod. 2020 May 22;45(3):e31. doi: 10.5395/rde.2020.45.e31. eCollection 2020 Aug.
4
Bifunctional Inhibitors as a New Tool To Reduce Cancer Cell Invasion by Impairing MMP-9 Homodimerization.双功能抑制剂作为一种通过损害MMP-9同二聚化来减少癌细胞侵袭的新工具。
ACS Med Chem Lett. 2017 Feb 7;8(3):293-298. doi: 10.1021/acsmedchemlett.6b00446. eCollection 2017 Mar 9.
5
Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.基质金属蛋白酶-13中催化锌(II)离子的分子识别:基于结构的变构抑制剂向具有改善亲脂性配体效率的双结合模式抑制剂的进化。
Int J Mol Sci. 2016 Mar 1;17(3):314. doi: 10.3390/ijms17030314.